# Barfresh Food Group Inc.: financial statements, quarterly

BRFH · Nasdaq · CIK 1487197 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/brfh.md) · [Financials](/companies/brfh/financials.md) · [Filings](/companies/brfh/filings.md) · [Insiders](/companies/brfh/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/brfh/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [2,603](/filings/0001493152-24-042368.md) | [1,922 d](/filings/0001641172-25-000931.md) | [2,829](/filings/0001641172-25-008101.md) | [1,464](/filings/0001641172-25-023503.md) | [3,637](/filings/0001493152-25-021070.md) | [2,788 d](/filings/0001493152-26-016807.md) | [2,930](/filings/0001493152-26-023106.md) | [1,625](/filings/0001493152-26-038426.md) | [4,231](/filings/0001493152-25-021070.md) | [5,422 d](/filings/0001493152-26-016807.md) | [5,632](/filings/0001493152-26-023106.md) | [4,707](/filings/0001493152-26-038426.md) |
| Cost of revenue | $k | [1,690](/filings/0001493152-24-042368.md) | [1,280 d](/filings/0001641172-25-000931.md) | [1,659](/filings/0001641172-25-008101.md) | [955](/filings/0001641172-25-023503.md) | [2,377](/filings/0001493152-25-021070.md) | [2,058 d](/filings/0001493152-26-016807.md) | [2,030](/filings/0001493152-26-023106.md) | [1,119](/filings/0001493152-26-038426.md) | [2,679](/filings/0001493152-25-021070.md) | [5,266 d](/filings/0001493152-26-016807.md) | [4,599](/filings/0001493152-26-023106.md) | [4,857](/filings/0001493152-26-038426.md) |
| Gross profit | $k | [913](/filings/0001493152-24-042368.md) | [642 d](/filings/0001641172-25-000931.md) | [1,170](/filings/0001641172-25-008101.md) | [509](/filings/0001641172-25-023503.md) | [1,260](/filings/0001493152-25-021070.md) | [730 d](/filings/0001493152-26-016807.md) | [900](/filings/0001493152-26-023106.md) | [506](/filings/0001493152-26-038426.md) | [1,552](/filings/0001493152-25-021070.md) | [156 d](/filings/0001493152-26-016807.md) | [1,033](/filings/0001493152-26-023106.md) | [(150)](/filings/0001493152-26-038426.md) |
| Research and development | $k | [32.0](/filings/0001493152-24-042368.md) | [27.0 d](/filings/0001641172-25-000931.md) | [30.0](/filings/0001641172-25-008101.md) | [17.0](/filings/0001641172-25-023503.md) | [52.0](/filings/0001493152-25-021070.md) | [33.0 d](/filings/0001493152-26-016807.md) | [19.0](/filings/0001493152-26-023106.md) | [31.0](/filings/0001493152-26-038426.md) | [33.0](/filings/0001493152-25-021070.md) | [46.0 d](/filings/0001493152-26-016807.md) | [24.0](/filings/0001493152-26-023106.md) | [37.0](/filings/0001493152-26-038426.md) |
| Operating income | $k | [(475)](/filings/0001493152-24-042368.md) | [(696) d](/filings/0001641172-25-000931.md) | [(446)](/filings/0001641172-25-008101.md) | [(1,005)](/filings/0001641172-25-023503.md) | [(500)](/filings/0001493152-25-021070.md) | [(824) d](/filings/0001493152-26-016807.md) | [(738)](/filings/0001493152-26-023106.md) | [(868)](/filings/0001493152-26-038426.md) | [(260)](/filings/0001493152-25-021070.md) | [(1,566) d](/filings/0001493152-26-016807.md) | [(436)](/filings/0001493152-26-023106.md) | [(1,517)](/filings/0001493152-26-038426.md) |
| Interest expense | $k | [1.0](/filings/0001493152-24-042368.md) | [5.0 d](/filings/0001641172-25-000931.md) | [3.0](/filings/0001641172-25-008101.md) | [6.0](/filings/0001641172-25-023503.md) | [13.0](/filings/0001493152-25-021070.md) | [28.0 d](/filings/0001493152-26-016807.md) | [23.0](/filings/0001493152-26-023106.md) | [12.0](/filings/0001493152-26-038426.md) | [30.0](/filings/0001493152-25-021070.md) | [152 d](/filings/0001493152-26-016807.md) | [23.0](/filings/0001493152-26-023106.md) | [77.0](/filings/0001493152-26-038426.md) |
| Income tax | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $k | [(476)](/filings/0001493152-24-042368.md) | [(701) d](/filings/0001641172-25-000931.md) | [(449)](/filings/0001641172-25-008101.md) | [(1,011)](/filings/0001641172-25-023503.md) | [(513)](/filings/0001493152-25-021070.md) | [(852) d](/filings/0001493152-26-016807.md) | [(761)](/filings/0001493152-26-023106.md) | [(880)](/filings/0001493152-26-038426.md) | [(290)](/filings/0001493152-25-021070.md) | [(763) d](/filings/0001493152-26-016807.md) | [(661)](/filings/0001493152-26-023106.md) | [(1,861)](/filings/0001493152-26-038426.md) |
| Diluted EPS | $ per share | [(0.04)](/filings/0001493152-24-042368.md) | not reported | [(0.03)](/filings/0001641172-25-008101.md) | [(0.07)](/filings/0001641172-25-023503.md) | [(0.03)](/filings/0001493152-25-021070.md) | not reported | [(0.05)](/filings/0001493152-26-023106.md) | [(0.06)](/filings/0001493152-26-038426.md) | [(0.02)](/filings/0001493152-25-021070.md) | not reported | [(0.04)](/filings/0001493152-26-023106.md) | [(0.12)](/filings/0001493152-26-038426.md) |
| Basic EPS | $ per share | [(0.04)](/filings/0001493152-24-042368.md) | not reported | [(0.03)](/filings/0001641172-25-008101.md) | [(0.07)](/filings/0001641172-25-023503.md) | [(0.03)](/filings/0001493152-25-021070.md) | not reported | [(0.05)](/filings/0001493152-26-023106.md) | [(0.06)](/filings/0001493152-26-038426.md) | [(0.02)](/filings/0001493152-25-021070.md) | not reported | [(0.04)](/filings/0001493152-26-023106.md) | [(0.12)](/filings/0001493152-26-038426.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating, us-gaap:InterestExpense
- Income tax: not reported
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [1.0](/filings/0001493152-23-038384.md) | [1.9](/filings/0001641172-25-000931.md) | [1.2](/filings/0001493152-24-019816.md) | [0.4](/filings/0001493152-24-032201.md) | [0.4](/filings/0001493152-24-042368.md) | [0.2](/filings/0001493152-26-016807.md) | [1.9](/filings/0001641172-25-008101.md) | [0.7](/filings/0001641172-25-023503.md) | [1.9](/filings/0001493152-25-021070.md) | [0.3](/filings/0001493152-26-038426.md) | [1.8](/filings/0001493152-26-023106.md) | [0.3](/filings/0001493152-26-038426.md) |
| Current assets | $m | [3.2](/filings/0001493152-23-038384.md) | [4.2](/filings/0001641172-25-000931.md) | [4.1](/filings/0001493152-24-019816.md) | [2.7](/filings/0001493152-24-032201.md) | [3.1](/filings/0001493152-24-042368.md) | [2.7](/filings/0001493152-26-016807.md) | [4.8](/filings/0001641172-25-008101.md) | [3.3](/filings/0001641172-25-023503.md) | [5.7](/filings/0001493152-25-021070.md) | [4.2](/filings/0001493152-26-038426.md) | [6.2](/filings/0001493152-26-023106.md) | [3.8](/filings/0001493152-26-038426.md) |
| Total assets | $m | [4.0](/filings/0001493152-23-038384.md) | [4.8](/filings/0001641172-25-000931.md) | [4.7](/filings/0001493152-24-019816.md) | [3.3](/filings/0001493152-24-032201.md) | [3.8](/filings/0001493152-24-042368.md) | [3.3](/filings/0001493152-26-016807.md) | [5.3](/filings/0001641172-25-008101.md) | [3.8](/filings/0001641172-25-023503.md) | [6.8](/filings/0001493152-25-021070.md) | [12.8](/filings/0001493152-26-038426.md) | [14.8](/filings/0001493152-26-023106.md) | [12.7](/filings/0001493152-26-038426.md) |
| Current liabilities | $m | [2.7](/filings/0001493152-23-038384.md) | [2.3](/filings/0001641172-25-000931.md) | [2.1](/filings/0001493152-24-019816.md) | [1.5](/filings/0001493152-24-032201.md) | [2.2](/filings/0001493152-24-042368.md) | [2.6](/filings/0001493152-26-016807.md) | [2.5](/filings/0001641172-25-008101.md) | [1.7](/filings/0001641172-25-023503.md) | [4.5](/filings/0001493152-25-021070.md) | [11.0](/filings/0001493152-26-038426.md) | [5.8](/filings/0001493152-26-023106.md) | [5.3](/filings/0001493152-26-038426.md) |
| Total liabilities | $m | [2.7](/filings/0001493152-23-038384.md) | [2.3](/filings/0001641172-25-000931.md) | [2.2](/filings/0001493152-24-019816.md) | [1.7](/filings/0001493152-24-032201.md) | [2.4](/filings/0001493152-24-042368.md) | [2.7](/filings/0001493152-26-016807.md) | [2.5](/filings/0001641172-25-008101.md) | [1.7](/filings/0001641172-25-023503.md) | [4.9](/filings/0001493152-25-021070.md) | [11.5](/filings/0001493152-26-038426.md) | [13.2](/filings/0001493152-26-023106.md) | [12.8](/filings/0001493152-26-038426.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | [0.2](/filings/0001493152-24-042368.md) | [0.1](/filings/0001493152-26-016807.md) | [0.1](/filings/0001641172-25-008101.md) | [0.1](/filings/0001641172-25-023503.md) | [0.3](/filings/0001493152-25-021070.md) | [0.5](/filings/0001493152-26-038426.md) | [0.5](/filings/0001493152-26-023106.md) | [0.5](/filings/0001493152-26-038426.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | [0.1](/filings/0001493152-24-042368.md) | [0.1](/filings/0001493152-25-021070.md) | [0.1](/filings/0001641172-25-008101.md) | [0.1](/filings/0001641172-25-023503.md) | [0.3](/filings/0001493152-25-021070.md) | [0.3](/filings/0001493152-26-016807.md) | [0.3](/filings/0001493152-26-023106.md) | [0.3](/filings/0001493152-26-038426.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [1.3](/filings/0001493152-24-042368.md) | [2.5](/filings/0001493152-26-016807.md) | [2.5](/filings/0001641172-25-008101.md) | [1.7](/filings/0001641172-25-023503.md) | [1.4](/filings/0001493152-25-021070.md) | [0.6](/filings/0001493152-26-038426.md) | [2.8](/filings/0001493152-26-023106.md) | [2.0](/filings/0001493152-26-038426.md) | [1.9](/filings/0001493152-25-021070.md) | [1.3](/filings/0001493152-26-038426.md) | [1.7](/filings/0001493152-26-023106.md) | [(0.1)](/filings/0001493152-26-038426.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [59.0 d](/filings/0001493152-24-042368.md) | [(950) d](/filings/0001641172-25-000931.md) | [(769)](/filings/0001641172-25-008101.md) | [(780) d](/filings/0001641172-25-023503.md) | [5.0 d](/filings/0001493152-25-021070.md) | [(685) d](/filings/0001493152-26-016807.md) | [(506)](/filings/0001493152-26-023106.md) | [(1,069) d](/filings/0001493152-26-038426.md) | [(598) d](/filings/0001493152-25-021070.md) | [507 d](/filings/0001493152-26-016807.md) | [(2,382)](/filings/0001493152-26-023106.md) | [(669) d](/filings/0001493152-26-038426.md) |
| Capital expenditure | $k | not reported | not reported | not reported | not reported | [57.0 d](/filings/0001493152-25-021070.md) | [(8.0) d](/filings/0001493152-26-016807.md) | [28.0](/filings/0001493152-26-023106.md) | [66.0 d](/filings/0001493152-26-038426.md) | [(52.0) d](/filings/0001493152-25-021070.md) | [81.0 d](/filings/0001493152-26-016807.md) | [646](/filings/0001493152-26-023106.md) | [317 d](/filings/0001493152-26-038426.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [12.9](/filings/0001493152-23-038384.md) | [13.0](/filings/0001493152-24-019816.md) | [13.0](/filings/0001493152-24-032201.md) | [13.0](/filings/0001493152-24-042368.md) | [14.5](/filings/0001641172-25-008101.md) | [14.7](/filings/0001641172-25-023503.md) | [14.7](/filings/0001493152-25-021070.md) | [15.4](/filings/0001493152-26-023106.md) | [15.7](/filings/0001493152-26-038426.md) | [15.9](/filings/0001493152-25-021070.md) | [16.0](/filings/0001493152-26-023106.md) | [16.2](/filings/0001493152-26-038426.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 16,308,172 at 2026-08-11, from the cover of the [10-Q filed 2026-08-14](/filings/0001493152-26-038426.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.